Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CADOUX LIMITED Director's Dealing 2005

Aug 14, 2005

64620_rns_2005-08-14_b56bd957-08c2-481e-8218-70ec861027fc.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Rule 3.19.4.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity SOLBEC PHARMACEUTICALS LTD
IABN 85 061 289 218

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Anthony William Kiernan
Date of last notice 15 April 2005

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Direct and indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Central Manhattan Pty Ltd as trustee of the
A W Kiernan Superannuation Fund
as to $1,000,000$ options
Date of change 9 August 2005
No. of securities held prior to change 1,025,000 Ordinary Fully Paid Shares
3,500,000 Options
Class Ordinary shares and options
Number acquired 100,000 ordinary shares
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
\$8144.56
No. of securities held after change 1,125,000 Ordinary Fully Paid Shares
3,500,000 Options
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Purchase on market of 100,000
ordinary
shares

+ See chapter 19 for defined terms.

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract Nil
Nature of interest Nil
Name of registered holder
(if issued securities)
Nil
Date of change Nil
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to
which the interest has changed
Nil
Interest acquired Nil
Interest disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Nil
Interest after change Nil

Solbec/ASX/App3y-Kiernan 9-8-05

$\overline{\text{+ See chapter 19}}$ for defined terms.